This research reports enhanced antitumor effects of a bispecific antibody in colon cancer, suggesting potential for improved treatment outcomes with regorafenib.
Supplementary Figure 9 confirms abscopal tumor effects after local REG/bsAb treatment.
No takes yet. Share an insight, caveat, or question.
Okpalanwaka et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: